Teva Pharmaceutical Industries Limited to Present New Data on Its Innovative Therapies for Multiple Sclerosis and Parkinson’s Disease at the Upcoming 2009 American Academy of Neurology Annual Meeting
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced that several new studies addressing the Company’s innovative central nervous system (CNS) portfolio will be presented at the 61st Annual American Academy of Neurology meeting in Seattle starting April 28, 2009.